Attorneys General Urge Congress to Repeal Ensuring Patient Access and Effective Drug Enforcement Act of 2016
Home / News & Resources / NAAG Policy Letters / Attorneys General Urge Congress to Repeal Ensuring Patient Access and Effective Drug Enforcement Act of 2016
NAAG sent a letter to Congress urging them to repeal a 2016 federal law so registered drug manufacturers and distributors who have willfully contributed to the nation’s oversupply of opioids can be held accountable.
Lead States
Florida, Maryland, North Carolina, Oklahoma
Signatory States
AK, AL, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, VA, VI, VT, WA, WV
To provide you more clarity about how we collect, store and use personal information, and your rights to control that information, we have updated our privacy policy, which also explains how we use cookies. You consent to our cookies if you continue to use our website.I Agree
